Clearpoint Neuro Inc reports results for the quarter ended in December - Earnings Summary

Clearpoint Neuro

01/03/2023 22:13

* Clearpoint Neuro Inc  CLPT.OQ  reported a quarterly
adjusted
loss of 18 cents​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 20 cents per share.
    * Revenue rose 20.8% to $5.17 million from a year ago;
analysts
expected $5.19 million. 
    * Clearpoint Neuro Inc's reported EPS for the quarter was a
loss
of 18 cents​.
    * The mean earnings estimate of analysts had fallen by
about 18.7%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Clearpoint Neuro Inc shares had risen by 0.1% this
quarter.
    * The company reported a quarterly loss of $4.39 million.
    * Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 1
at 10:13 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.20          -0.18          Beat
 Sep. 30 2022      -0.19          -0.15          Beat
 Jun. 30 2022      -0.18          -0.18          Met
 Mar. 31 2022      -0.20          -0.17          Beat